Mineral

Copper

Copper (Cu, element 29)

Evidence TierAWADA NOT PROHIBITED

tuneTypical Dose

1-2 mg per day

watchEffect Window

Weeks to months for deficiency correction. Preventive effect is immediate when co-supplemented with zinc.

check_circleCompliance

WADA NOT PROHIBITED

Overview

Clinical Summary

Copper is an essential trace mineral required for energy production, antioxidant enzymes, connective tissue crosslinking, and iron handling. It is used to correct deficiency, often when zinc intake is high.

Restoring copper status corrects deficiency that can cause anemia, neutropenia, and neurologic dysfunction, especially with malabsorption or excessive zinc intake. Adequate copper supports collagen and elastin integrity and normal immune function. Minority associations include roles in pigmentation and cardiovascular biomarker patterns. Excess intake is harmful, so benefits depend on targeted correction rather than routine high dosing.

Essential cofactor for ceruloplasmin (iron metabolism), Cu/Zn SOD1 (antioxidant defense), lysyl oxidase (connective tissue), cytochrome c oxidase (mitochondrial respiration), and dopamine beta-hydroxylase (neurotransmitter synthesis). Supplementation context is almost exclusively zinc-induced copper deficiency prevention.

Outcomes

What This Is Expected To Influence

Primary Outcomes

  • Prevents zinc-induced copper deficiency when co-supplemented at 15:1 zinc:copper ratio
  • Corrects copper deficiency anemia and neutropenia

Secondary Outcomes

  • Restores ceruloplasmin-dependent iron mobilization
  • Supports SOD1 antioxidant activity

Safety

Contraindications and Interactions

Contraindications

  • Wilson's disease (absolute)
  • Hemochromatosis

Side effects

  • GI upset/nausea (especially on empty stomach)
  • Metallic taste
  • Abdominal cramps at higher doses

Interactions

  • Penicillamine (copper chelator, antagonizes supplementation)
  • Trientine (copper chelator)
  • Zinc (competitive absorption, take 2+ hours apart)
  • High-dose vitamin C reduced copper absorption
  • Antacids/PPIs (may reduce absorption)

Avoid if

  • Wilson's disease
  • Hemochromatosis
  • Not taking supplemental zinc (independent supplementation rarely appropriate)

Evidence

Study-level References

copper-SRC-001Case series
Sourceopen_in_new

Willis MS, Monaghan SA, Miller ML, McKenna RW, Perkins WD, Levinson BS, et al. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol. 2005;123(1):125-131. doi:10.1309/V6GVYW2QTYD5C5PJ. PMID:15762288.

Population: Three adults with anemia, neutropenia, and excess zinc exposure or zinc therapy, with marrow findings leading to diagnosis of copper deficiency.

Dose protocol: Copper supplementation after identifying zinc-associated copper deficiency

Key findings: Copper supplementation reversed zinc-associated anemia and neutropenia with improvement in copper status markers.

Notes: Case-series evidence. Strong safety relevance, but not a wellness-efficacy trial.

Paper content

This case series reinforces the classic zinc-copper antagonism: prolonged zinc exposure can produce clinically important copper deficiency with anemia, neutropenia, and neuropathic features. It is useful for safety framing, not for showing benefit from routine copper supplementation in already sufficient adults.

copper-SRC-002Clinical observation and case series
Sourceopen_in_new

Prasad AS, Brewer GJ, Schoomaker EB, Rabbani P. Hypocupremia induced by zinc therapy in adults. JAMA. 1978;240(20):2166-2168. PMID:359844.

Population: Adults with sickle cell anemia receiving prolonged oral zinc therapy.

Dose protocol: High-dose zinc (150 mg/day) without copper co-supplementation

Key findings: High-dose zinc therapy induced copper deficiency with sideroblastic anemia and neutropenia. Established the zinc-copper antagonism mechanism via metallothionein induction.

Notes: Foundational study establishing the zinc-copper interaction that drives modern co-supplementation recommendations.

Paper content

This foundational report established that prolonged high-dose zinc can drive clinically relevant copper depletion and hematologic abnormalities, and that copper supplementation can reverse them. It supports copper as a corrective or preventive cofactor in high-zinc regimens, not as a general wellness add-on.

copper-SRC-003Placebo-controlled supplementation study
Sourceopen_in_new

Fischer PW, Giroux A, L'Abbé MR. Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr. 1984;40(4):743-746. doi:10.1093/ajcn/40.4.743. PMID:6486080.

Population: Healthy adult men given placebo or zinc supplementation for 6 weeks.

Dose protocol: Zinc supplementation at various doses with controlled diet

Key findings: Demonstrated dose-dependent reduction in copper status markers with increasing zinc intake. Copper deficiency anemia developed with chronic excess zinc without copper co-supplementation.

Notes: Controlled feeding evidence supports monitoring copper status during longer high-zinc use.

Paper content

In healthy men, 50 mg/day of zinc for six weeks lowered a copper-dependent enzyme marker, supporting the idea that chronic moderate-to-high zinc exposure can erode copper status even before overt deficiency appears.

Guides

Setup

Help